1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Global TB Diagnostic Market 2015-2019

Global TB Diagnostic Market 2015-2019

  • July 2015
  • -
  • Infiniti Research Limited
  • -
  • 82 pages

About TB Diagnostics
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio’s analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.


Covered in this Report
The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

Key Geographies
- Americas
- APAC
- EMEA

Key Vendors
- Abbott
- Alere
- Becton, Dickinson
- F. Hoffmann-La Roche

Other Prominent Vendors
- Siemens
- BioMérieux
- Cepheid
- Hain Lifescience
- Hologic
- Ortho Clinical
- Epistem UK
- Eiken Chemical Japan
- Alere US

Market Driver
- High Prevalence of TB
- For a full, detailed list, view our report

Market Challenge
- Insensitivity of Spear Microscopy
- For a full, detailed list, view our report

Market Trend
- Intensification of Rapid Tests in Developing Countries
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global TB Diagnostic Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Prevalence and Incidence Rate
08. Advances in Technology
08.1 Second-generation Nucleic Acid Detection
08.2 Next-generation Nucleic Acid Detection
09. TB Diagnostics Pipeline
10. Market Segmentation by Disease Stage
10.1 Global Latent TB Diagnostics Market
10.2 Global Active TB Diagnostics Market
10.3 Global Drug Susceptibility Tests Market
11. Geographical Segmentation
11.1 Global TB Diagnostics Market in APAC
11.1.1 India
11.2 Global TB Diagnostics Market in Americas
11.2.1 Brazil
11.3 Global TB Diagnostics Market in EMEA
11.3.1 South Africa
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.2.1 Abbott Diagnostics
19.2.2 Alere
19.2.3 BD
19.2.4 Roche Diagnostics
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Diagnostics
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Geographical Presence
20.1.4 SWOT Analysis
20.2 Alere
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 BD
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue Segmentation by Business
20.3.5 Segmental Revenue Comparison 2013 and 2012
20.3.6 Revenue Segmentation by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Roche Diagnostics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
21. Other Reports in This Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global TB Diagnostics Market 2014-2019 ($ millions)
Exhibit 3: Incidence Rate per 100,000 Individuals 2013
Exhibit 4: High-burden Countries
Exhibit 5: Product Pipeline: TB Diagnostics
Exhibit 6: Segmentation of Global Active TB Diagnostics Market 2014
Exhibit 7: Segmentation of Global TB Diagnostics Market by Disease Stage 2014
Exhibit 8: Segmentation of Global TB Diagnostics Market by Geography 2014
Exhibit 9: India: Revenue Segmentation by Entity 2012
Exhibit 10: Public Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 11: Private Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 12: Brazil: Revenue Segmentation by Entity 2012
Exhibit 13: Brazil: Common TB Diagnostic Tests and Their Cost 2012
Exhibit 14: Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
Exhibit 15: South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
Exhibit 16: Diagnostic Tests and Costs by Sectors
Exhibit 17: South Africa: Segmentation of TB by Revenue 2012-2013
Exhibit 18: South Africa: Volume of Tests in Public Sector 2012-2013
Exhibit 19: South Africa: Volume of Tests in Private Sector 2012-2013
Exhibit 20: Key Takeaways: Abbott Diagnostics
Exhibit 21: Key Takeaways: Alere
Exhibit 22: Key Takeaways: BD
Exhibit 23: Key Takeaways: Roche Diagnostics
Exhibit 24: Abbott Diagnostics: Geographical Presence
Exhibit 25: Alere: Business Segmentation by Revenue 2013
Exhibit 26: Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 27: Alere: Geographical Segmentation by Revenue 2013
Exhibit 28: Product Categorization of BD
Exhibit 29: Revenue Segmentation of BD 2013
Exhibit 30: Revenue Comparison ($ millions)
Exhibit 31: Revenue Segmentation of BD by Geography 2013
Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 33: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical Segmentation by Revenue 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.